Drug intelligence / Profile preview

Satiatrim

Development stage
Unknown
Lead developer
Health Genesis
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Satiatrim is a dietary supplement and nutraceutical primarily utilized for weight management and the regulation of postprandial glucose levels. The active ingredient in Satiatrim is phaseolamin, a proteinaceous alpha-amylase inhibitor extracted from the white kidney bean (*Phaseolus vulgaris*). Phaseolamin functions by competitively binding to the active site of alpha-amylase enzymes in the saliva and pancreas, thereby obstructing the breakdown of dietary starches into oligosaccharides and simple sugars. This inhibition reduces the glycemic index of starchy meals and decreases the total caloric absorption from carbohydrates. Satiatrim is commonly marketed to individuals seeking non-pharmaceutical interventions for obesity, weight loss, and metabolic health support.

Brand names
Satiatrim
Other names
PhaseolaminWhite kidney bean extractSatia-Trim
02

Targets

AMY (Pancreatic alpha-amylase)

Beyond the preview

Go deeper on Satiatrim.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Satiatrim.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call